Today the Government of Canada announced $59.2 million to VIDO to support the development of its vaccine candidates and the expansion of its research facilities, including a National Centre for Pandemic Research.
Three University of Saskatchewan researchers have been awarded a total of $1.87 million by the Canadian Institutes for Health Research (CIHR) for projects involving fatty liver disease, high blood pressure, and Zika virus.
Canada’s Global Nexus for Pandemics and Biological Threats at McMaster University and VIDO at USask are working together to accelerate vaccine and drug development, human clinical trials and create new diagnostic tools.